Bovine-activated protein C, administered intravenously to dogs, increases the rate of lysis of whole blood clots. Protein C, bovine prothrombin, and diisopropylfluorophosphate-inactivated protein Ca do not increase the rate of lysis. Repeated infusions of protein Ca sustain rapid blood clot lysis, but neither elevate circulating fibrin-split products nor decrease circulating plasminogen levels. The administration of protein Ca results in the elevation of the levels of lysine-adsorbable plasminogen activator activity in the plasma. When partially purified concentrates of this activator are added to normal dog blood at the levels seen following protein Ca injection, the rate of clot lysis is similar to that seen after protein Ca injection. The addition of protein Ca to citrated whole blood in vitro, with the subsequent neutralization of protein Ca with antibodies, results in increased rates of lysis when plasma made from the treated blood is reinjected into the animal. The generation of fibrinolytic activity is dependent on both cellular and plasma components of blood. A model of protein Ca fibrinolytic activity has a minimum of two components: a secondary messenger formed by protein Ca action on blood cells and plasma, and the subsequent appearance of plasminogen activator in the animal in response to that messenger.
P C Comp, C T Esmon
Title and authors | Publication | Year |
---|---|---|
Trauma Induced Coagulopathy
E Gonzalez, HB Moore, EE Moore |
2016 | |
Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation
P Dinarvand, SM Hassanian, H Weiler, AR Rezaie |
Blood | 2015 |
Biofluid Mechanics
DA Rubenstein, W Yin, MD Frame |
Biofluid Mechanics | 2015 |
Handbook of Proteolytic Enzymes
FS Markland, S Swenson |
Handbook of Proteolytic Enzymes | 2013 |
Oxygen Transport to Tissue XXXV
SV Huffel, G Naulaers, A Caicedo, DF Bruley, DK Harrison |
2013 | |
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison |
2012 | |
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison |
2012 | |
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison |
2012 | |
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison |
2012 | |
Critical Care Obstetrics
WE Scorza, A Scardella |
Critical Care Obstetrics | 2011 |
Critical Care Obstetrics: Belfort/Critical Care Obstetrics
D Dizon-Townson |
Critical Care Obstetrics: Belfort/Critical Care Obstetrics | 2011 |
Oxygen Transport to Tissue XXXII
JC LaManna, MA Puchowicz, K Xu, DK Harrison, DF Bruley |
2011 | |
Oxygen Transport to Tissue XXXII
JC LaManna, MA Puchowicz, K Xu, DK Harrison, DF Bruley |
2011 | |
Regulation of the protein C anticoagulant and antiinflammatory pathways
AR Rezaie |
Current medicinal chemistry | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley |
2009 | |
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley |
2009 | |
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley |
2009 | |
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley |
2009 | |
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley |
2009 | |
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley |
2009 | |
Post‐translational Modification of Protein Biopharmaceuticals
G Walsh |
2009 | |
Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells
JS Bae, L Yang, AR Rezaie |
Journal of Thrombosis and Haemostasis | 2008 |
Negative pressure dressing for promoting wound healing of purpura fulminans in a newborn with homozygous protein C deficiency
A Chuansumrit, N Kanogsunthornrat, N Sirachainan, S Porapakpenjun, R Chantarukha, S Warrasak, P Wongwerawattanakoon |
Blood Coagulation & Fibrinolysis | 2007 |
Negative pressure dressing for promoting wound healing of purpura fulminans in a newborn with homozygous protein C deficiency:
A Chuansumrit, N Kanogsunthornrat, N Sirachainan, S Porapakpenjun, R Chantarukha, S Warrasak, P Wongwerawattanakoon |
Blood Coagulation & Fibrinolysis | 2007 |
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
RM Bertina, NH van Tilburg, F Haverkate |
Journal of Thrombosis and Haemostasis | 2006 |
Cardiopulmonary bypass in patients with pre-existing coagulopathy
William DeBois, Junli Liu, Leonard Lee, Leonard Girardi, Wilson Ko, Anthony Tortolani, Karl Krieger, O Wayne Isom |
The Journal of Extra-Corporeal Technology | 2005 |
Platelet factor 4 modulation of the thrombomodulin–protein C system
A Slungaard |
Critical Care Medicine | 2004 |
Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats
IG Schoots, M Levi, AK van Vliet, AM Maas, EH Roossink, TM van Gulik |
Critical Care Medicine | 2004 |
Platelet factor 4 modulation of the thrombomodulin–protein C system:
A Slungaard |
Critical Care Medicine | 2004 |
Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats:
IG Schoots, M Levi, AK van Vliet, AM Maas, EH Roossink, TM van Gulik |
Critical Care Medicine | 2004 |
Platelet factor 4 enhances generation of activated protein C in vitro and in vivo
A Slungaard, JA Fernandez, JH Griffin, NS Key, JR Long, DJ Piegors, SR Lentz |
Blood | 2003 |
Activated protein C: Potential therapy for severe sepsis, thrombosis, and stroke
JH Griffin, B Zlokovic, JA Fernández |
Seminars in Hematology | 2002 |
Management of patients with severe sepsis, treated by drotrecogin alfa (activated)
PF Laterre, D Heiselman |
The American Journal of Surgery | 2002 |
Chelator, metal ion and buffer studies for protein C separation
H Wu, DF Bruley |
Comparative Biochemistry and Physiology - Part A Molecular & Integrative Physiology | 2002 |
Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease
O Stanger, M Weger, W Renner, R Konetschny |
Clinical Chemistry and Laboratory Medicine | 2001 |
Protein C Replacement in Severe Meningococcemia: Rationale and Clinical Experience
L Alberio, B Lammle, CT Esmon |
Clinical Infectious Diseases | 2001 |
Vitronectin Functions as a Cofactor for Rapid Inhibition of Activated Protein C by Plasminogen Activator Inhibitor-1: IMPLICATIONS FOR THE MECHANISM OF PROFIBRINOLYTIC ACTION OF ACTIVATED PROTEIN C
AR Rezaie |
The Journal of biological chemistry | 2001 |
Modeling zymogen protein C
L Perera, C Foley, TA Darden, D Stafford, T Mather, CT Esmon, LG Pedersen |
Biophysical Journal | 2000 |
Activated protein C prevents multiple organ injury following extensive hepatectomy in cirrhotic rats
A Yoshikawa, T Kaido, S Seto, Y Katsuura, M Imamura |
Journal of Hepatology | 2000 |
Modeling Zymogen Protein C
L Perera, C Foley, TA Darden, D Stafford, T Mather, CT Esmon, LG Pedersen |
Biophysical Journal | 2000 |
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation
P Gresele, S Momi, M Berrettini, GG Nenci, HP Schwarz, N Semeraro, M Colucci |
Journal of Clinical Investigation | 1998 |
Protein C Anticoagulant System in Patients with Interstitial Lung Disease
H Kobayashi, EC Gabazza, O Taguchi, H Wada, H Takeya, J Nishioka, H Yasui, T Kobayashi, O Hataji, K Suzuki, Y Adachi |
American journal of respiratory and critical care medicine | 1998 |
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis
PA von Borne, L Bajzar, JC Meijers, ME Nesheim, BN Bouma |
Journal of Clinical Investigation | 1997 |
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD |
The Annals of Thoracic Surgery | 1997 |
The 2.8 A crystal structure of Gla-domainless activated protein C
T Mather, V Oganessyan, P Hof, R Huber, S Foundling, C Esmon, W Bode |
The EMBO Journal | 1996 |
Morphological and hemostatic changes in rats with abdominal arterial prosthesis
E Chabielska, V Kolpakov, MC D'Adamo, AD Curtis, W Buczko, L Iacoviello, MB Donati |
Thrombosis Research | 1996 |
Coronary artery bypass graft surgery in a patient with hereditary protein S deficiency
HP Grocott, F Clements, K Landolfo |
Journal of Cardiothoracic and Vascular Anesthesia | 1996 |
25. Hämophilie-Symposion Hamburg 1994
I Scharrer, W Schramm |
1996 | |
Angiology in Practice
AM Salmasi, A Strano |
1996 | |
Purpura fulminans in severe congenital protein C deficiency: Monitoring of treatment with protein C concentrate
, W Ehrenthal, G Hafner, D Schranz |
European Journal of Pediatrics | 1996 |
Human protein C and activated protein C
FJ Castellino |
Trends in Cardiovascular Medicine | 1995 |
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
L Bajzar, R Manuel, ME Nesheim |
The Journal of biological chemistry | 1995 |
A comparative study of partial primary structures of the catalytic region of mammalian protein C
M Murakawa, T Okamura, T Kamura, M Kuroiwa, M Harada, Y Niho |
British Journal of Haematology | 1994 |
Plasma protein c activity is enhanced by arsenic but inhibited by fluorescent humic acid associated with blackfoot disease
HL Yang, SC Tu, FJ Lu, HC Chiu |
American Journal of Hematology | 1994 |
Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis
JA Tomczak, RA Ando, HG Sobel, EG Bovill, GL Long |
Thrombosis Research | 1994 |
Construction, Expression, and Properties of a Recombinant Chimeric Human Protein C with Replacement of Its Growth Factor-like Domains by Those of Human Coagulation Factor IX
S Yu, L Zhang, A Jhingan, WT Christiansen, FJ Castellino |
Biochemistry | 1994 |
Properties of Recombinant Chimeric Human Protein C and Activated Protein C Containing the .gamma.-Carboxyglutamic Acid and Trailing Helical Stack Domains of Protein C Replaced by Those of Human Coagulation Factor IX
WT Christiansen, FJ Castellino |
Biochemistry | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates
SR Hanson, JH Griffin, LA Harker, AB Kelly, CT Esmon, A Gruber |
Journal of Clinical Investigation | 1993 |
Protein C activator from the venom of Agkistrodon blomhoffi ussuriensis retards thrombus formation in the arterio-venous shunt in rats
AE Kogan, GV Bashkov, ID Bobruskin, EP Romanova, VA Makarov, SM Strukova |
Thrombosis Research | 1993 |
Neutralization of plasminogen activator inhibitor-1 (PAI-1) by activated protein C is species-dependent
P Grailhe, A Bezeaud, P Gaussem, MC Guillin, E Anglés-Cano |
Fibrinolysis | 1993 |
Shock, Sepsis, and Organ Failure
G Schlag, H Redl, D Traber |
1993 | |
The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation
L Bajzar, M Nesheim |
The Journal of biological chemistry | 1993 |
Effect of matrices on affinity purification of protein C
K Kang, D Ryu, WN Drohan, CL Orthner |
Biotechnology and Bioengineering | 1992 |
Protein C, protein S and C4b-binding protein in neonatal severe infection and septic shock
J Román, F Velasco, F Fernandez, M Fernandez, R Villalba, V Rubio, A Torres |
Journal of Perinatal Medicine | 1992 |
Blockade of protein C activation reduces microvascular surgical blood loss
RA Squires, S Smith, LR Pennington, PC Comp |
Journal of Surgical Research | 1992 |
Biological risk factors for sudden death in patients with coronary artery disease and without heart failure
P Lauribe, D Benchimol, JF Dartigues, S Dada, H Benchimol, F Drouillet, J Bonnet, H Bricaud |
International Journal of Cardiology | 1992 |
Purpura fulminans méningococcique : Particularités physiopathologiques
F Thomas, Y Ravaud |
Réanimation Urgences | 1992 |
Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs
J Fareed, P Bacher, HL Messmore, JM Walenga, DA Hoppensteadt, A Strano, R Pifarre |
Progress in Cardiovascular Diseases | 1992 |
Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant
MA Richardson, B Gerlitz, BW Grinnell |
Nature | 1992 |
Cardiovascular Biomaterials
GW Hastings |
1992 | |
Influence of specific gamma-carboxyglutamic acid residues on the integrity of the calcium-dependent conformation of human protein C
L Zhang, FJ Castellino |
The Journal of biological chemistry | 1992 |
Acquired protein S deficiency
B Kemkes-Matthes |
The Clinical Investigator | 1992 |
The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system
M Hessing |
Biochemical Journal | 1991 |
Species specificity of the fibrinolytic effects of activated protein C
RE Weinstein, FJ Walker |
Thrombosis Research | 1991 |
Proteins C and S in patients with advanced prostatic cancer
PD Oliveira, MG Oliveira, F Pina, JA Andrade, JM Pina-Cabral |
Thrombosis Research | 1991 |
The role of fibrinolytic factors in ischaemia
M Pandolfi, A Al-Rushood |
Eye | 1991 |
The role of the endothelium in in vivo anticoagulation
GT Housholder |
Journal of Oral and Maxillofacial Surgery | 1991 |
Activated protein C: Antithrombotic properties and influence on fibrinolysis in an animal model
J Römisch, KH Diehl, G Reiner, EP Paques |
Fibrinolysis | 1991 |
Recombinant Technology in Hemostasis and Thrombosis
LW Hoyer, WN Drohan |
1991 | |
Deep Venous Thrombosis and Pulmonary Embolism in Pregnancy
SE Rutherford, JP Phelan |
Obstetrics and Gynecology Clinics of North America | 1991 |
Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin
BW Grinnell, JD Walls, B Gerlitz |
The Journal of biological chemistry | 1991 |
Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction
RE Weinstein, FJ Walker |
Journal of Clinical Investigation | 1990 |
Low doses of activated protein C delay arterial thrombosis in rats
MD Smirnov, MV Pyzh, DV Borovikov, AN Atorozhilova, AB Dobrovolsky, VL Golubych, NA Gratsiansky |
Thrombosis Research | 1990 |
Effects of acetylthrombin on protein C activation and fibrinogen clotting
K Nakagomi, K Ajisaka, I Yokota |
Thrombosis Research | 1990 |
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis
A Gruber, SR Hanson, AB Kelly, BS Yan, N Bang, JH Griffin, LA Harker |
Circulation | 1990 |
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien |
1990 | |
The Endothelial Cytoskeleton: Organization in Normal and Regenerating Endothelium*
AI Gotlieb |
Toxicologic pathology | 1990 |
The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system
L Bajzár, JC Fredenburgh, M Nesheim |
The Journal of biological chemistry | 1990 |
Congenital severe protein C deficiency in adults
E Melissari, VV Kakkar |
British Journal of Haematology | 1989 |
Protein C Activity and Antigen in Premature and Fullterm Newborn Infants
R Bennhagen, L Holmberg |
Acta Paediatrica | 1989 |
Generation of anticoagulant and fibrinolytic activity of blood after intravenous injection of protein Ca into rats
AE Kogan, SM Strukova |
Bulletin of Experimental Biology and Medicine | 1989 |
Fibrinogenolysis in thrombotic thrombocytopenic purpura
E Kakishita, T Koyama, M Higuchi, O Kunitomi, Y Oura, K Nagai |
American Journal of Hematology | 1989 |
Rapid homogeneous enzyme immunoassay of plasma protein C
K Suzuki, T Hayashi, M Koyama, T Yoshimura, M Shimamoto, N Kimura, M Kita |
Clinica Chimica Acta | 1989 |
Purification and characterization of plasma protein C inhibitor
F España, M Berrettini, JH Griffin |
Thrombosis Research | 1989 |
Protein C : Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities
M Vasse, JY Borg, M Monconduit |
Thrombosis Research | 1989 |
Protein C assays in uremia
PJ Sørensen, F Knudsen, AH Nielsen, J Dyerberg |
Thrombosis Research | 1989 |
10 Protein C and protein S
G Dolan, J Ball, FE Preston |
Baillière's Clinical Haematology | 1989 |
Hemostasis in liver transplantation
RJ Porte, EA Knot, FA Bontempo |
Gastroenterology | 1989 |
Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C
WP Fay, WG Owen |
Biochemistry | 1989 |
Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy
J Grulich-Henn, K Loechelt, W Speiser, G Mller-Berghaus |
Blut Zeitschrift für die Gesamte Blutforschung | 1989 |
The Last Three Consecutive Epidermal Growth Factor-like Structures of Human Thrombomodulin Comprise the Minimum Functional Domain for Protein C-activating Cofactor Activity and Anticoagulant Activity
M Zushi, K Gomi, S Yamamoto, I Maruyama, T Hayashi, K Suzuki |
The Journal of biological chemistry | 1989 |
Conformational changes in an epitope localized to the NH2-terminal region of protein C
CL Orthner, RD Madurawe, WH Velander, WN Drohan, FD Battey, DK Strickland |
The Journal of biological chemistry | 1989 |
Characterization of a synthetic peptide that inhibits the interaction between protein S and C4b-binding protein
FJ Walker |
The Journal of biological chemistry | 1989 |
Tissue-Type Plasminogen Activator: A Review of its Pharmacology and Therapeutic Use as a Thrombolytic Agent
D Collen, HR Lijnen, PA Todd, KL Goa |
Drugs | 1989 |
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor
JA Koedam, JC Meijers, JJ Sixma, BN Bouma |
Journal of Clinical Investigation | 1988 |
Heparin Cofactor II, Antithrombin and Protein C in Plasma from Term and Preterm Infants
TR Andersson, H Bangstad, ML Larsen |
Acta Paediatrica | 1988 |
A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo
AR Giles, KG Mann, ME Nesheim |
British Journal of Haematology | 1988 |
Protein C in Acute Renal Failure
PJ Sørensen, F Knudsen, AH Nielsen, J Dyerberg |
Acta Medica Scandinavica | 1988 |
Immunological and functional determination of the protease inhibitors, protein C and antithrombin III, in liver cirrhosis and in neoplasia
KH Zurborn, W Kirch, HD Bruhn |
Thrombosis Research | 1988 |
Immunoblotting studies of the molecular forms of protein C in plasma
MJ Heeb, HP Schwarz, T White, B Lämmle, M Berrettini, JH Griffin |
Thrombosis Research | 1988 |
Immunoradiometric assays for the Ca(II)-dependent and Ca(II)-independent conformation of human protein C
SR Poort, PP Deutz-Terlouw, A Wijngaarden, RM Bertina |
Thrombosis Research | 1988 |
The dermatologist and protein C
SJ Miller |
Journal of the American Academy of Dermatology | 1988 |
The role of protein C in congenital and acquired thrombotic disorders
GT Housholder |
Journal of Oral and Maxillofacial Surgery | 1988 |
Effect of activated protein c on the fibrinolytic components released by cultured bovine aortic endothelial cells
Y Sakata, JH Griffin, DJ Loskutoff |
Fibrinolysis | 1988 |
Protein C inhibitor/plasminogen activator inhibitor 3
M Geiger |
Fibrinolysis | 1988 |
Hemostatic Abnormalities in Nephrotic Syndrome
R Abdullah |
Veterinary Clinics of North America Small Animal Practice | 1988 |
Haemostatic Aspects of Renal Transplantation
PJ Sørensen, EB Schmidt, F Knudsen, AH Nielsen, SD Kristensen, J Dyerberg, HJ Kornerup |
Scandinavian Journal of Urology and Nephrology | 1988 |
Genital Necrosis Secondary to Warfarin Therapy
RJ Kandrotas, J Deterding |
Nature Communications | 1988 |
Protein C in acute stroke
A D'Angelo, G Landi, S Vigano'D'Angelo, EN Orazio, E Boccardi, L Candelise, PM Mannucci |
Stroke; a journal of cerebral circulation | 1988 |
Endothelial Cell Biology in Health and Disease
N Simionescu, M Simionescu |
1988 | |
Vascular Endothelium in Health and Disease
S Chien |
1988 | |
Biotechnology in blood transfusion
CT Sibinga, PC Das, LR Overby |
1988 | |
Calcium binding to the epidermal growth factor homology region of bovine protein C
AK Ohlin, S Linse, J Stenflo |
The Journal of biological chemistry | 1988 |
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
KL Moore, SP Andreoli, NL Esmon, CT Esmon, NU Bang |
Journal of Clinical Investigation | 1987 |
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
FB Taylor, A Chang, CT Esmon, A D'Angelo, S Vigano-D'Angelo, KE Blick |
Journal of Clinical Investigation | 1987 |
Die immunologische und funktionelle Protein C-Bestimmung bei verschiedenen internistischen Erkrankungen
KH Zurborn, H Broers, W Kirch, N Jäger, HD Bruhn |
Klinische Wochenschrift | 1987 |
Thrombogenic and Nonthromboge0nic Biological Surfaces
JF Mustard, HM Groves, RL Kinlough-Rathbone, MA Packham |
Annals of the New York Academy of Sciences | 1987 |
Trans–Activated Expression of Fully Gamma–Carboxylated Recombinant Human Protein C, an Antithrombotic Factor
BW Grinnell, DT Berg, J Walls, SB Yan |
Bio/Technology | 1987 |
Clinical Implications of the Protein C/Protein S System
PC Comp |
Annals of the New York Academy of Sciences | 1987 |
Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis
W Speiser, J Wojta, C Korninger, JC Zazgornik, BR Binder |
Kidney International | 1987 |
Biochemical and functional properties of protein C and protein S
DK Strickland, CM Kessler |
Clinica Chimica Acta | 1987 |
Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S
RD Rosenberg, KA Bauer |
Human Pathology | 1987 |
Protein C functional assay using snake venom activator
IV Nathan, H Ping, MM Pradhan |
Thrombosis Research | 1987 |
Oral contraceptives reduce total protein S, but not free protein S
IA Huisveld, JE Hospers, JC Meijers, AE Starkenburg, WB Erich, BN Bouma |
Thrombosis Research | 1987 |
Human protein c induces anticoagulation and increased fibrinolytic activity in the cat
MD Burdick, RG Schaub |
Thrombosis Research | 1987 |
Characterization of the protein C activator protac® from the venom of the southern copperhead (Agkistrodon contortrix) snake
K Stocker, H Fischera, J Meier, M Brogli, L Svendsen |
Toxicon | 1987 |
The effect of stanozolol on various types of defective fibrinolysis
L Tengborn |
Fibrinolysis | 1987 |
The New Dimensions of Warfarin Prophylaxis
S Wessler, CG Becker, Y Nemerson |
1987 | |
New Trends in Diagnosis and Management of Stroke
K Poeck, EB Ringelstein, W Hacke |
1987 | |
16. Hämophilie-Symposion
G Landbeck, R Marx |
1987 | |
The protein C system in patients undergoing cardiopulmonary bypass
PN Knöbl, P Zilla, R Fasol, MM Müller, TC Vukovich |
The Journal of Thoracic and Cardiovascular Surgery | 1987 |
Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3
MJ Heeb, F España, M Geiger, D Collen, DC Stump, JH Griffin |
The Journal of biological chemistry | 1987 |
Topographical relationships between the monovalent and divalent cation binding sites of des-1-41-light chain bovine plasma protein C and des-1-41-light chain-activated bovine plasma protein C
KA Hill, FJ Castellino |
The Journal of biological chemistry | 1987 |
Calcium-dependent interaction between the epidermal growth factor precursor-like region of human protein C and a monoclonal antibody
AK Ohlin, J Stenflo |
The Journal of biological chemistry | 1987 |
Congenital thrombotic disorders
GM Rodgers, MA Shuman |
American Journal of Hematology | 1986 |
Fibrinolytic system of cultured endothelial cells: Regulation by plasminogen activator inhibitor
DJ Loskutoff, T Ny, M Sawdey, D Lawrence |
Journal of Cellular Biochemistry | 1986 |
Low protein C in the neonatal period
M Karpatkin, PM Mannucci, M Bhogal, S Vigano, M Nardi |
British Journal of Haematology | 1986 |
Clinical relevance of protein C
I Pabinger |
Blut | 1986 |
Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase-prednisone-vincristine therapy for leukaemia
CH Pui, CM Chesney, PW Bergum, CW Jackson, SI Rapaport |
British Journal of Haematology | 1986 |
Assay of protein c in human plasma: Comparison of amidolytic, coagulation, and immunochemical assays
F Espana, A Estellés, J Aznar, J Gilabert |
Thrombosis Research | 1986 |
Fibrinolytic study in a homozygous protein C deficient patient
J Aznar, A Dasi, F España, A Estellés |
Thrombosis Research | 1986 |
The Regulation of Hemostasis: The Protein C System
LH Clouse, PC Comp |
New England Journal of Medicine | 1986 |
Thromboembolic Disease in Pregnancy
SE Rutherford, JP Phelan |
Clinics in Perinatology | 1986 |
Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury
AE Annamalai, GJ Stewart, B Hansel, M Memoli, HC Chiu, DW Manuel, K Doshi, RW Colman |
Arteriosclerosis (Dallas, Tex.) | 1986 |
2. Rundtischgespräch Therapiebedingte Infektionen und Immundefekte bei Hämophilen
G Landbeck, R Marx |
1986 | |
8 Advances in Clinical Fibrinolysis
LW Hessel, C Kluft |
Clinics in Haematology | 1986 |
5 The Natural Anticoagulants
HH Salem |
Clinics in Haematology | 1986 |
Clinical relevance of protein C
I Pabinger |
Blut Zeitschrift für die Gesamte Blutforschung | 1986 |
Die Bedeutung des Endothels der Gefäßwand für die Aufrechterhaltung der Hämostase
U Delvos, G Müller-Berghaus |
Klinische Wochenschrift | 1985 |
Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity
Y Sakata, S Curriden, D Lawrence, JH Griffin, DJ Loskutoff |
Proceedings of the National Academy of Sciences | 1985 |
Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion
H Bounameaux, P Gresele, M Hanss, FD Cock, J Vermylen, D Collen |
Thrombosis Research | 1985 |
A new function for activated protein C: Activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes — platelet suspensions stimulated by phorbol diester
FB Taylor, MS Lockhart |
Thrombosis Research | 1985 |
Protein C activity in renal disease
PJ Sørensen, F Knudsen, AH Nielsen, J Dyerberg |
Thrombosis Research | 1985 |
Thromboembolism, Coumarin Necrosis, and Protein C
FJ Kazmier |
Mayo Clinic Proceedings | 1985 |
Antithrombotic Potential of Pentoxifylline A Hemorheologically Active Drug
RH Schröer |
Angiology | 1985 |
Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2
F Morito, H Saito, K Suzuki, S Hashimoto |
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 1985 |
Protein C antigen in prothrombin complex concentrates: Content, recovery and half life
H Riess, T Binsack, E Hiller |
Blut Zeitschrift für die Gesamte Blutforschung | 1985 |
Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis
AR Wintzen, AW Broekmans, RM Bertina, E Briet, PE Briet, A Zecha, GJ Vielvoye, GT Bots |
BMJ : British Medical Journal | 1985 |
Aktueller Stand der Thrombolysetherapie
J van de Loo, F Asbeck |
1985 | |
The Role of Endothelium in the Homeostatic Balance of Haemostasis
P Nawroth, W Kisiel, D Stern |
Clinics in Haematology | 1985 |
Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line
DB Wilson, HH Salem, JS Mruk, I Maruyama, PW Majerus |
Journal of Clinical Investigation | 1984 |
Natural anticoagulant mechanisms
RD Rosenberg, JS Rosenberg |
Journal of Clinical Investigation | 1984 |
Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys
M Colucci, JM Stassen, D Collen |
Journal of Clinical Investigation | 1984 |
Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity
RI Levin, PC Harpel, D Weil, TS Chang, DB Rifkin |
Journal of Clinical Investigation | 1984 |
Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells
EG Levin, U Marzec, J Anderson, LA Harker |
Journal of Clinical Investigation | 1984 |
Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation
AR Giles, ME Nesheim, KG Mann |
Journal of Clinical Investigation | 1984 |
The fibrinolytic system in man
AP Reiner, WR Bell |
Critical Reviews in Oncology/Hematology | 1984 |
Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator
J Stibbe, C Kluft, EJ Brommer, M Gomes, DS de Jong, J Nauta |
European Journal of Clinical Investigation | 1984 |
Protein C Mangel — Risikofaktor für venöse Thrombosen
HG Klingemann, AW Broekmans, RM Bertina, R Egbring, EA Loeliger |
Klinische Wochenschrift | 1984 |
Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy
S Viganò, PM Mannucci, S Solinas, B Bottasso, G Mariani |
British Journal of Haematology | 1984 |
FAMILIAL VENOUS THROMBOEMBOLISM AND INHERITED ABNORMALITIES OF THE BLOOD CLOTTING SYSTEM
AS Callus |
Australian and New Zealand Journal of Medicine | 1984 |
The relationship between thrombomodulin expression and cell cycle stages in cultured rabbit endothelial cells
LE Debault, NL Esmon, CT Esmon |
Cytometry | 1984 |
Haemostatic effects of stanozolol in elderly medical patients
M Small, JA MacLean, BM McArdle, RM Bertina, GD Lowe, CD Forbes |
Thrombosis Research | 1984 |
A new method for the estimation of protein C by ELISA
C Boyer, C Rothschild, M Wolf, J Amiral, D Meyer, MJ Larrieu |
Thrombosis Research | 1984 |
Protein C levels in activated and non-activated prothrombin complex concentrates
J Fareed, Z Parvez, HL Messmore, G Mariani, DA Walz |
Thrombosis Research | 1984 |
A model for thrombin protection against endotoxin
FB Taylor, A Chan, LB Hinshaw, CT Esmon, LT Archer, BK Beller |
Thrombosis Research | 1984 |
Response of Protein C and Protein C inhibitor to warfarin therapy in patient with combined deficiency of factors V and VIII
MM Bern, K Suzuki, K Mann, P Tracy, L Hoyer, W Jensen, M Gallivan, C Arkin, G Davis |
Thrombosis Research | 1984 |
The fibrinolytic system in patients with congenital protein C deficiency
J Conard, MH Horellou, AC Teger-Nilsson, RM Bertina, M Samama |
Thrombosis Research | 1984 |
Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol
C Kluft, RM Bertina, FE Preston, RG Malia, SL Blamey, GD Lowe, CD Forbes |
Thrombosis Research | 1984 |
Severe homozygous protein C deficiency
RH Sills, RA Marlar, RR Montgomery, GN Deshpande, JR Humbert |
The Journal of Pediatrics | 1984 |
Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the Newborn
U Seligsohn, A Berger, M Abend, L Rubin, D Attias, A Zivelin, SI Rapaport |
New England Journal of Medicine | 1984 |
Molecular Bad Actors and Thrombosis
VJ Marder |
New England Journal of Medicine | 1984 |
Biology of Endothelial Cells
EA Jaffe |
1984 | |
Haemostatic Failure in Liver Disease
P Fondu, O Thijs |
1984 | |
INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANT
HE Branson, R Marble, J Katz, JH Griffin |
The Lancet | 1983 |
A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis
J Soria, C Soria, JP Caen |
British Journal of Haematology | 1983 |
FIBRINOGEN HETEROGENEITY
MW Mosesson |
Annals of the New York Academy of Sciences | 1983 |
A functional assay for protein C in human plasma
RB Francis, MJ Patch |
Thrombosis Research | 1983 |
Human fibrinogen heterogeneities: Determination of the major aα chain derivatives in blood
DK Galanakis, MW Mosesson |
Thrombosis Research | 1983 |
New Comprehensive Biochemistry
S Yamamoto |
New Comprehensive Biochemistry | 1983 |
Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor
NW Stead, KA Bauer, TR Kinney, JG Lewis, EE Campbell, MA Shifman, RD Rosenberg, SV Pizzo |
The American Journal of Medicine | 1983 |
Activation of protein C in vivo
PC Comp, RM Jacocks, GL Ferrell, CT Esmon |
Journal of Clinical Investigation | 1982 |
Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease
WM Canfield, W Kisiel |
Journal of Clinical Investigation | 1982 |
DEFICIENCIES OF PROTEIN C, AN INHIBITOR OF BLOOD COAGULATION
PM Mannucci, S Vigano |
The Lancet | 1982 |
Cardiopulmonary Bypass in Patients With Pre-existing Coagulopathy
William DeBois, Junli Liu, Leonard Lee, Leonard Girardi, Wilson Ko, Anthony Tortolani, Karl Krieger, O. Wayne Isom |
The Journal of Extra-Corporeal Technology | |
Kinetic mechanism for stimulation by monovalent cations of the amidase activity of the plasma protease bovine activated protein C
SA Steiner, FJ Castellino |
Biochemistry | 1985 |
The Role of Natural Coagulation Inhibitors in Hemostasis
JT Brandt |
Clinics in Laboratory Medicine | 1984 |
New approaches to thrombolytic therapy
D Collen, HR Lijnen |
Arteriosclerosis (Dallas, Tex.) | 1984 |
Contribution of thrombogenic factors to the pathogenesis of atherosclerosis
S Niewiarowski, AK Rao |
Progress in Cardiovascular Diseases | 1983 |
The Physiology of Hemostasis
D Ogston |
1983 | |
Protein C inhibitor. Purification from human plasma and characterization
K Suzuki, J Nishioka, S Hashimoto |
The Journal of biological chemistry | 1983 |
Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C
NL Esmon, LE DeBault, CT Esmon |
The Journal of biological chemistry | 1983 |
Inactivation of human coagulation factor V by activated protein C
K Suzuki, J Stenflo, B Dahlbäck, B Teodorsson |
The Journal of biological chemistry | 1983 |
Effects of parathyroid hormone and vitamin D on the renal vitamin K-dependent carboxylating system
PI Karl, PA Friedman |
The Journal of biological chemistry | 1983 |
Kinetic studies of the role of monovalent cations in the amidolytic activity of activated bovine plasma protein C
SA Steiner, FJ Castellino |
Biochemistry | 1982 |
Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation
CT Esmon, NL Esmon, KW Harris |
The Journal of biological chemistry | 1982 |
Amino acid sequence of the light chain of bovine protein C
P Fernlund, J Stenflo |
The Journal of biological chemistry | 1982 |
Blut und Blutkrankheiten
L Heilmeyer, K Betke, KG von Boroviczény, D Busch, E Grundmann, H Heimpel, G Hoffmann, W Hunstein, W Keiderling, M Matthes, H Merker, W Müller, P Pfannenstiel |
1968 |